Sheehan D V, Harnett-Sheehan K
University of South Florida, Institute for Research in Psychiatry, Tampa 33613-4706, USA.
J Clin Psychiatry. 1996;57 Suppl 10:51-8; discussion 59-60.
This article reviews all available studies reported in the literature or presented at national or international meetings on the efficacy of serotonin selective reuptake inhibitors and less selective serotonin uptake inhibitors in panic disorder. The research data lags behind-rather than leads-experience in everyday clinical practice. The emerging data suggest that serotonin uptake inhibitors are superior to placebo and better tolerated than most of the older alternatives. As a result they are now becoming first-choice treatments in panic disorder.
本文综述了文献中报道的或在国内或国际会议上展示的所有关于5-羟色胺选择性再摄取抑制剂和选择性稍低的5-羟色胺摄取抑制剂治疗惊恐障碍疗效的现有研究。研究数据滞后于日常临床实践中的经验而非引领经验。新出现的数据表明,5-羟色胺摄取抑制剂优于安慰剂,且耐受性比大多数传统替代药物更好。因此,它们现在正成为惊恐障碍的首选治疗方法。